Rapid DNA Testing Break-Even: $150K Monthly Revenue Target
A rapid DNA testing laboratory breaks even at about $1504K in monthly revenue under the Year 1 assumptions Here’s the quick math: fixed monthly expenses are about $1248K, variable expenses run 17% of revenue, so contribution margin is 83% At the planned Year 1 mix, that equals about 231 billable samples per month, versus planned volume of 516 samples and revenue of $3368K The model shows operating break-even in Month 1, but cash still dips to -$1305M in Month 6 because startup capex is separate from recurring break-even
Test whether monthly revenue covers variable expenses and fixed monthly costs for rapid DNA testing.
Money available to cover fixed costs$589,667
$706,188 revenue - $116,521 variable expenses
Margin ratio
84%
Covers fixed costs
Yes
Break-even chart Revenue Total costs
Which rapid DNA testing expenses are fixed, and which move with sample volume?
Cost classification
Break-even only works if fixed lab overhead is covered after per-test spend. In the first operating year, kits and reagents at 8% plus consumables at 4% reduce each revenue dollar before overhead is paid.
Expense
Cost
Break-Even Treatment
Common Mistake
Laboratory Facility Rent
Fixed
Include $25,000 per month in monthly overhead.
Treating lab space as scalable with samples.
Utilities Lab & Office
Fixed
Include $4,000 per month in overhead.
Ignoring the baseline lab load.
Secure IT Infrastructure & Software Licenses
Fixed
Include $6,000 per month in overhead.
Pushing secure storage into per-test spend only.
Laboratory Accreditation & Renewals
Semi-fixed
Include $3,000 per month, with step-ups as scale or compliance scope changes.
Excluding compliance from break-even.
Insurance General Liability & Professional Indemnity
Fixed
Include $2,500 per month in overhead.
Treating required coverage as optional.
DNA Testing Kits & Reagents
Variable
Subtract 8% of revenue before covering fixed overhead.
Using gross revenue as margin.
Laboratory Consumables
Variable
Subtract 4% of revenue as volume-linked test spend.
Forgetting supplies scale with testing volume.
Base Staffing Wages
Fixed
Include first-year planned salaries of about $75,833 per month.
Modeling core lab staff as fully variable.
How does break-even change from a lean launch to base and full-capacity rapid DNA testing?
Scenario table
Break-even shifts because revenue scales faster than variable costs while fixed overhead stays about $1,248K. Lean is basically at zero profit, but base and full capacity add a wider cushion as sample volume rises.
Planning cases only; one-time capex and financing sit outside recurring break-even.
Scenario
Monthly Revenue
Variable Costs
Fixed Costs
CM Ratio
Operating Profit
Break-Even Signal
Lean launch case
$1,504K
$256K
$1,248K
83%
$0K
At the threshold, so a small miss turns negative.
Base Year 1 plan
$3,368K
$573K
$1,248K
83%
$1,547K
Clear operating cushion, so the board case stays comfortably above break-even.
Full-capacity case
$5,110K
$869K
$1,248K
83%
$2,993K
Strong upside, but only if contract volume keeps the lab filled.
What breaks a rapid DNA lab’s break-even plan?
Stress test
Break-even is comfortable at the base case, but intake speed and cost drift can erase the cushion. A $10K monthly overhead bump or a move from 17% to 22% variable expense pushes the floor higher fast.
Stress Case
Changed Assumption
Break-Even Revenue
Revenue Gap
Risk Signal
Current plan
No change.
$1,504K
$1,864K cushion
Base case clears break-even by a wide margin.
Revenue shortfall
Monthly revenue falls to the $1,504K break-even floor.
$1,504K
$0 gap
Any further intake slowdown creates losses.
Fixed-cost increase
Monthly payroll or overhead rises by $10K.
$1,516K
$1,852K cushion
Extra overhead narrows the cushion but still clears break-even.
Margin pressure
Variable expenses rise from 17% to 22%.
$1,600K
$1,768K cushion
Higher reagent use and rework raise the floor.
Combined pressure
Variable expenses rise to 22% and fixed costs add $10K.
$1,613K
$1,755K cushion
Slow intake plus cost creep can close the gap fast.
What should you verify before signing the lab lease and buying rapid DNA equipment?
Founder checklist
Don’t commit to the full lab cost base until you can prove sample flow, price mix, and staffing can cover it. The model looks profitable on paper, but Month 6 cash still falls to about -$1.305M, so operating break-even and cash readiness are not the same thing.
1Demand Proof231 samples/mo
Verify you can hold at least 231 samples a month before you lock the full cost base, or the lease and instrument spend will outrun real demand.
2Launch Demand516 samples/mo
Only scale to the 516-sample target if agency, forensic, or identification work is real enough to fill the wider lab and support the bigger operating plan.
3Staffing Ramp8 FTEs / $71.7K/mo
Year 1 payroll runs about $71.7K a month across 8 FTEs, so confirm the workflow can handle that team before you add more hires.
4Overhead Load$49K/mo
Non-payroll fixed overhead is about $49K a month, and that rent, IT, accreditation, insurance, marketing, and admin load has to fit the sample pipeline.
5Unit Margin83% CM
Check that billable work stays in the $500 to $1,500 range, with 12% COGS plus 5% variable costs, so the 83% contribution margin still holds before payroll.
6Cash Cushion-$1.305M
Fund the Month 6 cash low of about -$1.305M separately from operating break-even, or a good margin story can still stall when startup cash runs thin.
Choosing a selection results in a full page refresh.